Skip to main content
Top
Published in: European Journal of Epidemiology 9/2013

01-09-2013 | Letter to the Editor

Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals

Authors: Jin-Young Min, Kyoung-Bok Min

Published in: European Journal of Epidemiology | Issue 9/2013

Login to get access

Excerpt

Connecting-peptide (C-peptide), a byproduct of proinsulin, is co-secreted with insulin in equimolar amounts from pancreatic β cells. Insulin is extracted by the liver and has a half-life of 3–5 min, whereas C-peptide is subjected to negligible first-pass metabolism by the liver and has a twofold to fivefold longer half-life than insulin and therefore, serves as a surrogate for endogenous insulin secretion [1]. C-peptide has been considered biologically inert and only clinically useful for identifying type 1 and type 2 diabetes mellitus [1]. …
Literature
1.
2.
go back to reference Ido Y, Vindigni A, Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (New York, NY). 1997;277(5325):563–6.CrossRef Ido Y, Vindigni A, Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (New York, NY). 1997;277(5325):563–6.CrossRef
3.
go back to reference Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35(2):121–8.PubMedCrossRef Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35(2):121–8.PubMedCrossRef
4.
go back to reference Irwin ML, Duggan C, Wang CY, et al. Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(1):47–53.CrossRef Irwin ML, Duggan C, Wang CY, et al. Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(1):47–53.CrossRef
5.
go back to reference Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol. 1999;68(2):179–86.PubMedCrossRef Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol. 1999;68(2):179–86.PubMedCrossRef
6.
go back to reference Bergstrom RW, Newell-Morris LL, Leonetti DL, et al. Association of elevated fasting C-peptide and increased intraabdominal fat distribution with development of NIDDM in Japanese American men. Diabetes. 1990;39(1):104–11.PubMedCrossRef Bergstrom RW, Newell-Morris LL, Leonetti DL, et al. Association of elevated fasting C-peptide and increased intraabdominal fat distribution with development of NIDDM in Japanese American men. Diabetes. 1990;39(1):104–11.PubMedCrossRef
7.
go back to reference Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais. J Clin Lab Anal. 2007;21(2):85–90.PubMedCrossRef Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais. J Clin Lab Anal. 2007;21(2):85–90.PubMedCrossRef
8.
go back to reference Chen CH, Tsai ST, Chuang JH, Chang MS, Wang SP, Chou P. Population-based study of insulin, C-peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol. 1995;76(8):585–8.PubMedCrossRef Chen CH, Tsai ST, Chuang JH, Chang MS, Wang SP, Chou P. Population-based study of insulin, C-peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol. 1995;76(8):585–8.PubMedCrossRef
9.
go back to reference Efrat S. Prospects for treatment of type 2 diabetes by expansion of the beta-cell mass. Diabetes. 2001;50(Suppl 1):S189–90.PubMedCrossRef Efrat S. Prospects for treatment of type 2 diabetes by expansion of the beta-cell mass. Diabetes. 2001;50(Suppl 1):S189–90.PubMedCrossRef
10.
go back to reference Porte D Jr. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes/Metab Res Rev. 2001;17(3):181–8.CrossRef Porte D Jr. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes/Metab Res Rev. 2001;17(3):181–8.CrossRef
Metadata
Title
Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals
Authors
Jin-Young Min
Kyoung-Bok Min
Publication date
01-09-2013
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 9/2013
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-013-9836-5

Other articles of this Issue 9/2013

European Journal of Epidemiology 9/2013 Go to the issue